<http://schema.org/description>
"An investigation published by the BMJ today raises concern about the motives behind post-marketing studies of new treatments for diabetes and calls for better regulation to ensure &amp;quot;a proper balance&amp;quot; between the commercial and clinical functions of these studies."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-06-post-marketing.html>